On Mar. 17, 2022, Eiger BioPharmaceuticals announced that Peginterferon Lambda (Lambda) significantly reduced the risk of COVID-19-related hospitalizations…
On Mar. 17, 2022, Soligenix announced the results of a booster vaccination study using CiVax (heat stable COVID-19…
On Mar. 17, 2022, Moderna announced that it had submitted a request to the U.S. Food and Drug…
On Mar. 16, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Mar. 16, 2022, Roche announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate…
On Mar. 16, 2022, Moderna announced an agreement with the Ministry of Health, Labour and Welfare of Japan…
On Mar. 15, 2022, Pfizer and BioNTech announced the companies had submitted an application to the U.S. Food…
On Mar. 14, 2022, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…
On Mar. 14, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection (APHIS) Service confirmed…
On Mar. 11, 2022, the BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDCﾒs Advisory Committee on Immunization…
On Mar. 10, 2022, Oragenics announced that it had entered into an agreement with KBI Biopharma for the…
On Mar. 10, 2022, Moderna announced that the first participant had been dosed in the Phase 2 study…
On Mar. 10, 2022, the Illinois Department of Agriculture (IDOA), in conjunction with the Illinois Department of Natural…
On Mar. 10, 2022, Cocrystal Pharma announced dosing of the first subjects in a Phase 1 clinical trial…
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
On Mar. 10, 2022, a COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to…
On Mar. 10, 2022, Howard Hughes Medical Institute announced that after more than two decades of effort researchers…
On Mar. 9, 2022, Harvard Medical School announced that an international research team had completed an atlas of…
On Mar. 9, 2022, Pfizer announced that it had initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease…
On Mar. 9, 2022, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) announced a clinical…
On Mar. 4, 2022, Oxitec announced the publication by the U.S. Environmental Protection Agency of its approval to…
On Mar. 7, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
On Mar. 7, 2022, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
On Mar. 7, 2022, Moderna announced that with the assistance of the U.S. Government, it had entered into…
On Mar. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had made a low-risk determination…
On Mar. 4, 2022, the U.S. Centers for Disease Control and Prevention (CDC) reported that COVID-19 vaccination coverage with…
On Mar. 4, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Mar. 4, 2022, the WHO announced it had published an updated position paper on the RTS,S/AS01 (RTS,S)…
On Mar. 3, 2022, a study carried out in southwestern Ontario identified a highly mutated variant of SARS-CoV-2…
On Mar. 3, 2022, the World Health Organization (WHO) and the Medicines Patent Pool (MPP) jointly welcomed the announcement…